Founded in 2019, Genestat Molecular Diagnostics specializes in engineering, manufacturing, and delivering all the necessities for PCR testing, setting themselves apart with their expert guidance. In addition to developing assays, the company offers tools and clarification for every step of the testing process. This encompasses collection and transport kits with proprietary components, reporting software, standards, controls, instruments, and configuration. Their comprehensive approach aims to assist customers in navigating the world of molecular testing to achieve reliable results.
As of now, there is no information available regarding the company's industries, headquarter location, or any recent investments and investors.